Travi Giovanni M, Schnall Bruce M, Lehman Sharon S, Kelly Christopher J, Hug Denise, Hirakata Vânia N, Calhoun Joseph H
Wills Eye Hospital, Philadelphia, PA, USA.
J AAPOS. 2005 Oct;9(5):449-54. doi: 10.1016/j.jaapos.2005.06.001.
We sought to assess the success of amblyopia treatment in patients with small posterior lens opacities as well as the factors associated with a good visual outcome.
This was a retrospective study of patients with posterior lens opacities that initially were thought to be too small in size to warrant cataract surgery. The following variables were examined: cataract type, location, diameter, persistent hyaloid vessel, anisometropia, strabismus, and age of detection. Success of treatment of amblyopia was defined as improvement by at least 0.3 logMAR units. Good visual outcome was defined as 20/40 or better. Amblyopia was treated by glasses, patching, and/or atropine. Patients who failed with conservative treatment or had an increase in cataract size underwent surgery.
Forty-eight (91%) of 53 eyes were amblyopic. Thirty amblyopic eyes had pre- and post-treatment Snellen acuities. Twenty (67%) had their visual acuity (VA) improved by 0.3 logMAR units or greater. None of the measured variables were associated with successful amblyopia treatment. Twenty-five (49%) of 51 patients had a final VA of 20/40 or better. The only variable associated with good visual outcome was cataract type: 18 of 25 (72%) posterior subcapsular cataract and 6 of 23 (32%) posterior lenticonus eyes achieved VA of 20/40 or better (P = 0.008). Six patients who went on to have cataract surgery experienced a larger improvement in BCVA (4.50 logMar units +/- 2.52 lines) compared with patients treated without cataract surgery (2.36 logMar units +/- 3.11 lines).
Amblyopia treatment was successful in most cases. A small group of patients who underwent cataract surgery experienced a greater VA improvement; however, it was not statistically significant. Further studies are needed to determine which patients would benefit from cataract surgery.
我们试图评估患有小的晶状体后混浊的患者弱视治疗的成功率以及与良好视力预后相关的因素。
这是一项对晶状体后混浊患者的回顾性研究,这些患者最初被认为混浊尺寸太小,无需进行白内障手术。检查了以下变量:白内障类型、位置、直径、永存玻璃体动脉、屈光参差、斜视和发现时的年龄。弱视治疗成功定义为视力至少提高0.3 logMAR单位。良好的视力预后定义为20/40或更好。弱视通过眼镜、遮盖和/或阿托品进行治疗。保守治疗失败或白内障尺寸增大的患者接受手术。
53只眼中有48只(91%)患有弱视。30只弱视眼有治疗前和治疗后的斯内伦视力。20只(67%)视力提高了0.3 logMAR单位或更多。所测量的变量均与弱视治疗成功无关。51名患者中有25名(49%)最终视力达到20/40或更好。与良好视力预后相关的唯一变量是白内障类型:25只后囊下白内障眼中的18只(72%)和23只后圆锥形晶状体眼中的6只(32%)视力达到20/40或更好(P = 0.008)。与未接受白内障手术的患者(2.36 logMar单位±3.11行)相比,6名接受白内障手术的患者最佳矫正视力提高幅度更大(4.50 logMar单位±2.52行)。
大多数情况下弱视治疗是成功的。一小部分接受白内障手术的患者视力提高幅度更大;然而,这在统计学上并不显著。需要进一步研究以确定哪些患者将从白内障手术中获益。